GABAA Rγ2 Activators encompass a diverse set of chemical compounds that directly or indirectly enhance the functional activity of the GABAA Rγ2 receptor, a pivotal component of the inhibitory neurotransmission system. Allosteric modulators such as Allopregnanolone and neuroactive steroids like Pregnenolone Sulfate bind to distinct sites on the receptor, increasing GABAA Rγ2 sensitivityto GABA and resulting in an intensified inhibitory effect. Similarly, compounds like Muscimol and Zolpidem directly engage the GABA binding site or the benzodiazepine site on the receptor, respectively, to potentiate the receptor's response to its primary neurotransmitter, GABA. They induce a conformational change in the receptor that leads to a prolonged opening of the chloride channel, enhancing the hyperpolarization of the neuronal membrane. Ethanol and Isoflurane, although diverse in structure, both serve as positive allosteric modulators, stabilizing the receptor in its open state, thereby facilitating an increase in chloride ion conductance and amplifying GABAA Rγ2-mediated inhibitory signaling.
On the other hand, compounds like Flumazenil, though typically characterized as an antagonist, at specific concentrations can enhance the effects of GABA on the receptor by inducing subtle conformational changes. Similarly, Barbiturates and Benzodiazepines, including Phenobarbital and Diazepam, bind to their respective sites on the receptor complex, increasing the duration and frequency of chloride channel opening events. This action leads to a greater inhibitory effect on neuronal excitability, which is a direct consequence of augmented GABAA Rγ2 receptor activity. Lastly, Taurine, an endogenous modulator, and Picrotoxin, through its paradoxical effect of receptor desensitization, both contribute to the upregulation and heightened functional state of GABAA Rγ2 receptors. Collectively, these activators demonstrate a multifaceted approach to increasing the functional activity of GABAA Rγ2, each interacting with the receptor or its immediate signaling environment to ensure a potentiated inhibitory response without altering the receptor's expression levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Muscimol | 2763-96-4 | sc-200460 sc-200460A | 5 mg 25 mg | $161.00 $537.00 | 2 | |
Muscimol is a potent GABAA agonist that binds to the GABA binding site on GABAA Rγ2. This binding mimics the action of GABA and induces a conformational change that increases the opening of the chloride channel, leading to heightened receptor activity. | ||||||
Flumazenil (Ro 15-1788) | 78755-81-4 | sc-200161 sc-200161A | 25 mg 100 mg | $110.00 $370.00 | 10 | |
Flumazenil is a benzodiazepine antagonist, but at certain concentrations, it can act as a positive allosteric modulator of GABAA Rγ2. It reversibly binds to the benzodiazepine site, subtly changing receptor conformation to enhance GABA's effect. | ||||||
Pregnenolone sulfate sodium salt | 1852-38-6 | sc-301609 | 50 mg | $99.00 | 2 | |
Pregnenolone sulfate, despite being a negative modulator on some GABAA receptor subtypes, can enhance the activity of the GABAA Rγ2-containing receptors by allosterically modulating the receptor's response to GABA. | ||||||
Isoflurane | 26675-46-7 | sc-470926 sc-470926A | 5 g 25 g | $69.00 $219.00 | 7 | |
Isoflurane is a volatile anesthetic that enhances GABAA receptor activity. It binds to multiple sites on the GABAA receptor and potentiates GABA-induced chloride currents, thereby increasing GABAA Rγ2-mediated inhibitory neurotransmission. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
Picrotoxin is a non-competitive antagonist of GABAA receptors, but it can indirectly enhance GABAA Rγ2 activity by promoting receptor desensitization and reducing the receptor's responsiveness to GABA, leading to a compensatory upregulation of functional receptors. | ||||||
Taurine | 107-35-7 | sc-202354 sc-202354A | 25 g 500 g | $48.00 $102.00 | 1 | |
Taurine is an endogenous amino acid that acts as a positive allosteric modulator of GABAA receptors. It binds to a distinct site on the receptor, leading to an enhanced response to GABA and increased GABAA Rγ2 receptor activity. | ||||||